HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficiency and safety of long-term artrofoon treatment in rheumatoid arthritis.

Abstract
In patients with rheumatoid arthritis, prolongation of artrofoon therapy to 2 years led to maintenance of the positive clinical effect attained after 6-month treatment. Moreover, significant improvement was observed by some parameters (integral pain intensity, swelling index, Ritchie articular index, morning stiffness, and articular score). No side effects related to artrofoon treatment were observed throughout the treatment period in the main group. The results indicate high efficiency and good tolerability of the preparation and attest to advisability of its long-term use.
AuthorsV I Petrov, A R Babaeva, E V Cherevkova, M V Kachanova, Yu A Zabolotneva, S A Tarasov, Yu L Dugina, S A Sergeeva
JournalBulletin of experimental biology and medicine (Bull Exp Biol Med) Vol. 148 Issue 3 Pg. 486-8 (Sep 2009) ISSN: 1573-8221 [Electronic] United States
PMID20396719 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Artrofoon
Topics
  • Adult
  • Aged
  • Antibodies, Monoclonal (adverse effects, therapeutic use)
  • Antirheumatic Agents (adverse effects, therapeutic use)
  • Arthritis, Rheumatoid (drug therapy)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: